期刊文献+

维生素D水平与平均血小板体积变化的相关性研究 被引量:3

The Correlation Between the Vitamin D Level and Mean Platelet Volume
下载PDF
导出
摘要 目的 探讨维生素D水平与平均血小板体积(MPV)的相关性。方法 选取患者420例测定维生素D水平及MPV。根据测得维生素D水平将病例分为组1:维生素D〈10ng/mL;组2:维生素D为10~20ng/mL;组3:维生素D〉20ng/mL。比较各组检测结果,分析维生素D水平与MPV变化的相关性。结果 三组维生素D水平分别为8.9±2.1ng/mL,14.3±1.7 ng/mL,24.2±5.9 ng/mL,差异有统计学意义(P〈0.001)。三组患者MPV分别为8.3±1.7fL,8.0±1.4fL,7.3±1.5fL。组3与组1、组2 MPV差异有统计学意义(P〈0.001;P=0.006)。维生素D水平与MPV存在负相关(r2=0.337,P〈0.001)。结论 维生素D水平与MPV密切相关,维生素D的缺乏可能导致MPV升高。 Objective To investigate the correlation between the vitamin D level and mean platelet volume (MPV). Methods 420 patients were collected. According to the vitamin D level, the patients were allocated to Group 1 ( vitamin D 〈 10ng/mL), Group 2 ( vitamin D, 10-20ng/mL), Group 3 ( vitamin D 〉 20ng/mL), respectively. The vitamin D level and mean platelet volume in all patients were detected. Results The vitamin D level in Group 1 (7.7 ± 1.9ng/mL) was lower than that in Group 2 ( 14.3 ±1.7 ng/mL, P 〈0.001 ) and Group 3 (24.2 ±5.9 ng/mL, P 〈0.001 ). The MPV in Group 3 (7.3 ± 1.5 fL) was lower than that in Group 1 (8.3 ± 1.7 fL, P 〈0.001 ) and Group 2 (8.0 ± 1.4 fL,P =0.006). Linear regression analysis showed that low levels of vitamin D (r2 =0. 337 ,P 〈0.001 ) was independently associated with increased MPV. Conclusion The vitamin D level is closely related with MPV. The vitamin D deficiency would results in a higher MPV.
出处 《标记免疫分析与临床》 CAS 2015年第1期12-14,共3页 Labeled Immunoassays and Clinical Medicine
关键词 维生素D 平均血小板体积 心血管疾病 相关性 Vitamin D Mean platelet volume Cardiovascular diseases Correlation
  • 相关文献

参考文献1

二级参考文献36

  • 1Varol E, Akcay S, Icli A, et aI. Mean platelet volume in pa tients with prehypertension and hypertension. Clin Hemorheol Microcirc,2010,45:67-72.
  • 2Yarlioglues M, Kaya MG, Ardic I, et al. Oguzhan Relationship between mean platelet volume levels and subclinical target or gan damage in newly diagnosed hypertensive patients. Blood Press,2011,20:92-97.
  • 3Inane T,Kaya MG, Yarlioglues M, et al. The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives. Blood Press, 2010,19 :81 -85.
  • 4Kaya MG,Yarlioglues M, Gunebakmaz O, et al. Platelet acti ration and inflammatory response in patients with non-dipper hypertension. Atherosclerosis, 2010,209 : 278-282.
  • 5Boos CJ, Beevers GD, Lip GY. Assessment of platelet activa tion indices using the ADVIATM 120 amongst 'high-risk' patients with hypertension. Ann Med, Z007,39 : 72-78.
  • 6Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets, 2008, 19:115 118.
  • 7Celik T,Yuksel UC, Iyisoy A, et al. E{fects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoproloi. Int J CardioI, 2007,116 : 206-211.
  • 8Gasparyan AY. Aspirin and clopidogrel resistance: methodo logical challenges and opportunities. Vase Health Risk Man ag,2010,6:109 112.
  • 9Coban E, Kucuktag S, Basyigit S. Platelet activation in sub jects with impaired glucose tolerance. Platelets, 2007,18 : 591 594.
  • 10Zuberi BF,Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non diabetic subjects. Singapore Med J,2008,49= 114-116.

共引文献14

同被引文献13

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部